KLACID XL TABLET Afrika t’Isfel - Ingliż - South African Health Products Regulatory Authority (SAHPRA)

klacid xl tablet

abbott laboratories s.a. (pty) ltd - tablet - see ingredients - each tablet contains clarithromycin 500,0 mg

Atripla New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

atripla

gilead sciences (nz) - efavirenz 600mg;  ;  ;  ; emtricitabine 200mg;  ;  ;  ; tenofovir disoproxil fumarate 300mg;  ;  ;   - film coated tablet - active: efavirenz 600mg       emtricitabine 200mg       tenofovir disoproxil fumarate 300mg       excipient: croscarmellose sodium hyprolose magnesium stearate microcrystalline cellulose opadry pink 85f94172 purified water sodium laurilsulfate - atripla is indicated for the treatment of hiv infected adults over the age of 18 years, alone or in combination with other antiretroviral agents.

KLACID 250 Milligram Tablets Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

klacid 250 milligram tablets

g & a licensing limited - clarithromycin - tablets - 250 milligram

Klacid Hp7 Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

klacid hp7

abbott australasia pty ltd - clarithromycin; omeprazole; amoxycillin -

Klacid LA 500mg Modified release tablets Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

klacid la 500mg modified release tablets

mylan ire healthcare limited - clarithromycin - modified-release tablet - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections caused by susceptible organisms. indications include:  lower respiratory tract infections for example bronchitis and pneumonia.  upper respiratory tract infections for example sinusitis and pharyngitis.  skin and soft tissue infections for example folliculitis, cellulitis and erysipelas.

Klacid LA 500mg Modified release tablets Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

klacid la 500mg modified release tablets

viatris healthcare limited - clarithromycin - modified-release tablet - macrolides; clarithromycin